CatalystWireBeta

Final Results

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your ELIX notes

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, is pleased to announce its final results for the year ended 31 December 2023.

Financial Highlights

  • Revenue increased by 20% to £85.9m (FY 22: £71.7m)
  • Adjusted EBITDA* increased by 24% to £25.4m (FY 22: £20.5m)
  • Adjusted EBITDA* margin of 30% (FY 22: 29%)
  • Profit before tax increased by 40% to £22.1m (FY 22: £15.7​m)
  • Adjusted diluted earnings per share* increased by 22% to 37.2p (FY 22: 30.5p)
  • Year-end net cash of £18.1m (FY 22: £20.4m)
  • Total dividend increased by 37% to 14.8p per Ordinary share (FY 22: 10.8p)

* Adjusted EBITDA excludes the following items from operating profit: non-cash depreciation and amortisation charges, share-based payments and non-recurring M&A-related items. Adjusted EPS excludes the following items from profit after tax: amortisation charges, share-based payments, non-recurring M&A-related items, M&A-related non-cash finance costs and their related tax impacts.

Current Trading & Outlook

  • FY 23 momentum has continued into FY 24, with three record revenue months in Q1 2024 and a strong pipeline for the remainder of FY 24
  • Momentum is expected to continue throughout the remainder of the year, with FY 24 revenue expected to be in the range of £104-110 million
  • Adjusted EBITDA margin expected to be in the range of 27-29% after factoring in the impact of Insigniam's lower margins at acquisition

Operating Highlights

  • Continued progress executing our four-pillar growth strategy, including:
  • Stretching Existing Partners - revenue per Partner increased by 7% during the year to £3.9m per Partner (FY 22: £3.6m). This continues the growth in this metric in each year since listing.
  • Hiring new Partners - we made three successful Partner hires in FY 23. These individuals have expanded the Group's presence in key markets and geographies and ensure that diversity of thought is maintained throughout the Partner grade.
  • Promoting Partners from Within - two experienced Principals were promoted to Partner in January 2023, with a further two Principals promoted to Partner in October 2023. January 2024 saw our first promotion to Partner in one of our acquired businesses, reflecting its successful integration within the Elixirr Group.
  • Inorganic Growth - the acquisition of the Artificial Intelligence firm, Responsum, in September 2023 has positioned the Group at the forefront of cutting-edge technology, whilst the acquisition of organisational change and transformation firm, Insigniam, in December 2023 enables us to support clients, innovate and drive large-scale change. Inorganic growth remains a key component of our strategy, and our internal M&A team continues to generate a pipeline of strong prospects that will help us further support clients with key boardroom issues and maximise the growth opportunity for the Group.
  • Multiple accolades received including being named in the Financial Times' 2023 'UK Leading Management Consultants' list, earning a place on the Global Outsourcing 100® by the International Association of Outsourcing Professionals, being recognised as a Top Consulting Firm by Consultancy.UK and being shortlisted for the In-house Recruitment Awards 2023.

Commenting on the results, Founder & CEO, Stephen Newton said:

"2023 highlighted Elixirr's ability to thrive, outperforming both competitors and the global Consulting market. Our continued growth is a testament to the quality of our team, and the value we deliver to our clients. This year we continued to invest in our four-pillar growth strategy, further diversifying our offering and enabling us to solve new and interesting challenges for our clients. Our equity incentive model continues to disrupt the market, solidifying our reputation as the Challenger Consultancy and setting us up for continued success."

Non-Executive Chairman's Report

OVERVIEW

I am pleased to introduce Elixirr's 2023 Annual Results, a year which highlighted the strength and resilience of the Group. Through its broad and diversified service offering, the Group has continued to deliver exceptional results.

Elixirr solved a variety of complex client challenges during 2023, facilitated by its broad service offering and foundation in data, technology, and innovation. The Group performed particularly well in scaling its existing client base, and its strong level of client retention demonstrates how in demand its expertise continues to be.

The Group grew both organically and inorganically in 2023, benefiting from its positioning in the market and increasing market awareness of the brand. The acquisition of the Artificial Intelligence firm, Responsum, in September 2023 has positioned the Group at the forefront of cutting-edge technology, whilst the acquisition of organisational change and transformation firm, Insigniam, in December 2023, enables us to support clients innovate and drive large-scale change. These acquisitions are highly complementary to the Group's existing offering, having driven further expansion into the US - a key growth market for the Group - and position the firm well to help clients address current and future disruptive market trends.

STRATEGY

The Board continues to have confidence in the Group's four-pillar growth strategy which has further demonstrated its value in FY 23. Through driving both organic and inorganic growth, the strategy has again proven highly successful despite challenging market conditions.

The Group's incentivisation model encourages the Partner team to act like entrepreneurs, with the team motivated to achieve growth for the Group, rather than solely at an individual level. As such, emphasis has been placed on selling services across the Elixirr Group, increasing client penetration, breadth of service and longevity of relationship as a result. Through future organic and inorganic growth, we expect to increase the breadth of services offered to clients even further.

We remain confident that the four-pillar growth strategy will drive future growth for the Group, as we have a team that is highly incentivised to achieve organic growth, together with a strong pipeline of new acquisition targets.

DIVIDEND

Given the continued growth of the business and in line with comparable companies, the Board has decided to declare two dividends per year, with an interim dividend payable shortly after the end of the financial year and a final dividend payable in August. As a result of the strong performance in FY 23 and the year-end cash position, the Company paid an interim Ordinary share dividend of 5.3p per share on 15 February 2024.

The Board is pleased to recommend a final Ordinary share dividend for FY 23 of 9.5p per share, making a total dividend of 14.8p for the FY 23 financial year, a 37% increase on the FY 22 dividend.

The final dividend will be recommended to shareholders at the AGM in June 2024. The FY 23 final dividend will have a total cash cost of £4.5 million, which will be funded from the Group's existing cash reserves.

GOVERNANCE

The Board operates within a robust governance framework and throughout FY 23, has ensured that the Group complies with the corporate governance code of the Quoted Companies Alliance (QCA). This includes ensuring that the Group has a balance of diverse skills and experience to deliver our strategy and growth objectives. The Board and its subcommittees include independent non-executive members with varying backgrounds and experience. The Board continues to monitor this on a regular basis.

OUTLOOK

The Board is optimistic about the outlook for FY 24, given the Group's track record of achieving its ambitions and its commitment to further growth. The growth of the business to date, underpinned by the support of our shareholders, clients and people, positions Elixirr well to continue its strong performance.

Gavin Patterson

Non-Executive Chairman

Chief Executive Officer's Report

OVERVIEW

Elixirr's performance in FY 23 has again highlighted the firm's ability to grow profitably in both bull and bear markets. As always, our firm's key differentiator is the quality of our people, and I would like to thank our growing teams across the globe for their continued dedication and commitment.

Elixirr continued to perform well in FY 23, with revenue growing at a CAGR of 37% from 2019 to 2023. This sustained growth can be attributed to the increasing breadth of our services and a truly differentiated proposition, centred around the technology of tomorrow, which ensures that we continue to outperform the global consulting market (2019 to 2022 CAGR of 8.4%, source: Statista).

Our four-pillar growth strategy continues to provide the foundation for Elixirr's performance, ensuring a balance of both organic and inorganic growth. The acquisitions of Insigniam and Responsum brought new in-demand capabilities to the Group in FY 23, and enhanced Elixirr's presence in additive industries and geographies. Such acquisitions diversify our existing offering, increasing our resilience in all market conditions, and enable us to solve new and exciting challenges for our clients.

FY 23 PERFORMANCE

In FY 23, the business generated revenue of £85.9 million - a 20% increase from the prior year (£71.7 million). We focused on both winning new clients across the Group and deepening existing client relationships. This resulted in a 12% increase in the number of 'gold' client accounts - clients from which we receive annual revenue of over £1 million.

Throughout FY 23, Elixirr delivered a diverse range of solutions to our clients, across numerous industries and geographies. As a result of our continued growth, the firm now has a presence in six key geographies with eight offices across the globe, and diversification of revenue across nine core industries. Due to our broad service offering and deep knowledge of emerging technologies, we continue to be well placed to support clients with a wide range of business-critical challenges.

The revenue bridge above shows the elements of the growth in revenue from £71.7 million in FY 22 to £85.9 million in FY 23.

Underlying organic revenue growth was 15% year on year (net +£10.4 million revenue), with £11.5 million growth from existing clients and £10.4 million growth from new clients. This was partially offset by end-of-life projects which accounted for £11.5 million of lost revenue, including the impact of one very large, 5-year change programme successfully coming to an end.

The acquisition of Insigniam in December 2023 and iOLAP's revenue from the early part of the year (2.5 months in Q1) added £5.4 million to revenue overall in FY 23. In order to protect the overall profitability of the Group, management exited legacy lower margin revenue in acquired companies (-£1.6 million).

Elixirr achieved Adjusted EBITDA of £25.4 million in FY 23 - an increase in absolute terms of 24% from FY 22 (£20.5 million). This FY 23 Adjusted EBITDA represented 30% of revenue (FY 22: 29%), highlighting our ability to maintain market-leading levels of profitability and validating our position as a high value, high returns business.

We have been able to maintain this high level of profitability, despite acquiring businesses with historically lower margins, through increasing the value we deliver to our clients alongside removing inefficiencies. For the first time, both Elixirr Digital and iOLAP achieved margins similar to the core Consulting business in FY 23.

DELIVERING OUR FOUR-PILLAR GROWTH STRATEGY

Our aim is to become the best digital, data and AI consultancy in the world, and we have a clear and focussed four-pillar growth strategy that will enable us to achieve this goal. Progress has been made in each area of this strategy, including organic growth delivered by a collaborative Partner team that is heavily invested in Elixirr's growth journey, and inorganic growth resulting from the firm's mature acquisition strategy, process and pipeline.

In FY 23, revenue per Partner increased by 7% from £3.6 million in FY 22 to £3.9 million in FY 23, as set out in the Partner revenue bridge below. This continues the growth in this metric in each year since listing.

Stretching Existing Partners

A key component of our growth strategy is ensuring that established Partners maintain and improve their revenue contributions to the Elixirr Group. In FY 23, the established Partners in our firm generated average revenue of £4.8 million each - this was a 17% increase on the £4.1m achieved in FY 22.

Elixirr Partners are heavily incentivised to grow revenue and maintain margins and have been supported in doing so by an internal reorganisation into an industry vertical model. This makes us even more client-focussed. The senior members of the Partner team are accountable for growing specific industries, geographies, and capabilities, which will facilitate continued progress in this organic growth pillar.

We have also increased Partner revenue targets for FY 24, reflecting our expectations for further growth in this metric.

Hiring New Partners

Hiring external Partners with existing networks and consulting industry expertise is a key part of our growth strategy - bringing in individuals who expand the Group's presence in key markets and geographies. We successfully hired three new Partners in FY 23: a career consultant with experience founding a boutique consulting firm, a former managing director at Boston Consulting Group, and a former South African rugby captain turned entrepreneur. These candidates came through the network of the existing Partner team, and their respective backgrounds help to ensure that diversity of thought is maintained throughout the Partner grade.

In order to maintain the quality bar for which we are known, underperforming Partners were exited, with their equity positions forfeited. Management continues to take decisive action to protect the overall business and quality of our earnings.

In January 2024, we welcomed a new Partner to the team who brings award-winning expertise in growing and scaling companies and orchestrating successful exits. She will focus on driving growth for our clients, particularly in the technology and cybersecurity space, as well as generating new business development opportunities for the Group. We continually progress a warm pipeline of potential Partner candidates.

Promoting Partners from Within

Growing talent from within ensures that we retain our culture and quality as we scale, and we have embraced 'growing our own timber' since the day we were founded. Our strategy of giving promoted Partners a 'runway' to develop their Partner-level experience continued to pay off, with the promoted Partner team achieving £7.2 million revenue in FY 23.

In January 2023, Danielle Croucher and Ben Gower joined the Partner team, followed by Dan Coral and Rory Farquharson in October 2023. Each promoted Partner has been instrumental in our continued growth, both in the UK and US, and we have confidence that they will continue contributing to the Group's success worldwide as we scale.

In January 2024, Nick Larsen joined the Partner team. Nick is a longstanding member of the iOLAP team and is our first promotion to Partner in one of our acquired businesses. This is a significant milestone in our acquisition strategy, reflecting the successful integration of iOLAP within the Elixirr Group.

Acquiring New Businesses

Buying new businesses in key growth markets with additive capabilities to Elixirr's existing offering remains a key part of our growth strategy. In 2023, the acquisitions of Responsum and Insigniam opened doors to new clients, markets, and capabilities, and have generated significant growth potential.

In September 2023, Elixirr completed the acquisition of Responsum - a US-headquartered firm which has developed proprietary Artificial Intelligence ("AI") software. This acquisition brought specialist services in emerging technology, large language model and generative AI into the Group, complementing our existing service offering and iOLAP's data and analytics capabilities. This is a compelling opportunity for the Group, given that the global AI market is forecast to grow from US$208 billion in 2023 to US$1.8 trillion by 2030 (source: Statista). Consequently, we are well-positioned to capitalise upon the growing demand from clients for support in understanding how to implement and benefit from AI. Since the acquisition of Responsum was announced in September, several joint client engagements have been won and delivered, with most looking likely to extend, and multiple other active conversations are being closed out.

In December 2023, Elixirr completed the acquisition of Insigniam - a US and France headquartered consultancy firm, specialising in supporting clients and executives to define and navigate large scale change and transformation. This acquisition brought specialist services in transformation, leadership alignment, cultural change and executive coaching to Elixirr, complementing the Group's existing service offerings. Insigniam also has deep expertise in additive industries for Elixirr and has built a reputation as a market leader within the healthcare, biopharmaceuticals and life sciences industries. Insigniam's top clients include Fortune 500 companies and household brands, providing significant opportunities for the cross sell of services across the Elixirr Group.

We have a dedicated internal M&A team that continues to generate a pipeline of strong prospects, based on strict criteria, focused on bringing in additional capabilities that will help us to support clients with key boardroom issues. They remain focused on bringing in high-quality businesses that will maximise the growth opportunity for the Group.

OUR FIRM

I am truly proud of our team of bold entrepreneurs who have consistently delivered high-calibre work and value for our clients throughout the year.

The equity schemes offered by Elixirr instil a culture of entrepreneurship in our people, with everyone working together for, and able to benefit from, the growth of the Group. Our Employee Share Purchase Plan ("ESPP") had high levels of participation again for the new financial year - over 45% for the Group and over 75% for the consulting business for FY 24, highlighting the commitment that our teams have to the Elixirr growth story. We are particularly pleased that 70% of Insigniam employees elected to participate in the ESPP in the first year following the acquisition, indicating how strongly this proposition resonates for all employees across the Elixirr Group.

Our team continues to be diverse in skillset and experience, sourced from the world's best universities, industry roles and start-ups. We pride ourselves on the diversity of thought present within the Group, with more than 120 distinct University degrees studied within the Consulting team alone.

Elixirr's focus on cutting edge technologies differentiates us from traditional incumbents in the Consulting industry. Our broad range of capabilities and platform model offers our talent the opportunity to develop different expertise across multiple industries, geographies and service lines. In FY 23, we received over 10,000 job applications across the Elixirr Group, evidencing the strength of our employee proposition.

In 2023 we were pleased to receive multiple accolades including being named in the Financial Times' 2023 'UK Leading Management Consultants' list, earning a place on the Global Outsourcing 100® by the International Association of Outsourcing Professionals, being recognised as a Top Consulting Firm by Consultancy.UK and being shortlisted for the In-house Recruitment Awards 2023. These awards highlight our unwavering commitment to delivering value for our clients in addition to the quality of our internal functions.

OUTLOOK

Elixirr's continued growth in FY 23, despite challenging market conditions, once again highlights the resilience of our firm, talent of our people, and strength of our model.

As we look to the future, it is clear that emerging technology will have a significant impact on the Consulting industry and the evolution of services that clients will demand in the future. Given our focus on the technology of tomorrow, this provides a huge growth opportunity for Elixirr's core service offering, and our investments in this space to date position us well for future success.

Momentum has continued into FY 24, with three record revenue months in Q1 2024. We expect this momentum to continue over the rest of the year and, therefore, are targeting FY 24 revenue in the range of £104-110 million. After factoring in the impact of Insigniam's lower margins at acquisition, we expect our Adjusted EBITDA margin to be in the range of 27-29%.

Stephen Newton

Founder & Chief Executive Officer

Financial Review

FY 23FY 22% change
Revenue£85.9m£71.7m+20%
Gross profit£29.3m£23.2m+26%
Adjusted EBITDA*£25.4m£20.5m+24%
Adjusted EBITDA margin*30%29%+1PP
Profit before tax£22.1m£15.7m+40%
Adjusted diluted earnings per share*37.2p30.5p+22%
Dividend per share14.8p10.8p+37%
Free cash flow£16.1m£14.6m+11%
Net cash£18.1m£20.4m-11%

* In order to provide better clarity to the underlying performance of the Group, Elixirr uses adjusted EBITDA and adjusted earnings per share ('EPS') as alternative performance measures ('APMs'). Please refer to note 3 of the Group and Company Financial Statements for further details.

GROUP RESULTS

The Board is pleased to report another strong year of growth for the Group, both organically and as a result of the FY 23 acquisitions of Responsum and Insigniam and the FY22 acquisition of iOLAP. The Group achieved double-digit growth in both revenue and profits and this is testament to the continued effectiveness of our four-pillar growth strategy.

Our broad service offering and deep knowledge of emerging technologies meant we continued to be well placed to support an expanding client base with a wide range of business-critical challenges. During FY 23 we delivered a diverse range of solutions to our clients, across numerous industries and geographies, and successfully acquired Responsum and Insigniam, integrating their service offerings and teams into the Group. The acquisitions opened doors to new clients, markets, and capabilities, and have generated significant growth potential for future years.

The Group delivered healthy, industry-leading margins and strong cash generation, closing out the year in a financially sound position. In FY 23 the Group delivered revenue of £85.9 million (FY 22: £71.7 million), with profitability continuing to be strong. Adjusted EBITDA was £25.4 million, reflecting a 30% margin (FY 22: £20.5 million at a 29% margin).

REVENUE

Revenue increased by 20% to £85.9 million in FY 23 compared with £71.7 million in FY 22, with five record months of revenue achieved during the year. Revenue growth was driven by both underlying organic revenue growth of 15% and the impact of the acquisitions.

Double-digit revenue growth was achieved across all geographic regions (UK, USA and Rest of World) in which the Group operates, having increased our US footprint further following the acquisitions of Responsum and Insigniam. US revenue continues to account for 44% of Group revenue (FY 22: 44%). We are also pleased to report that revenue per client-facing Partner grew by 7% during the year, with established Partners having increased by 17%. This reflects the quality and resilience of our Partner team and how the growing suite of capabilities provided by our acquisitions have expanded the range of services that our Partners can sell to their clients.

The sustained increase in the Group's revenue highlights persistent high demand for its current service portfolio, coupled with the strategic integration of new service capabilities acquired through acquisitions. The Responsum and Insigniam businesses have complemented Elixirr's core consulting services, offering a range of additional solutions that meet client needs.

GROUP PROFITABILITY

The Group's revenue growth was accompanied by robust profit expansion. Group gross profit reached £29.3 million in the year, marking a notable £6.1 million increase or 26% growth compared to the previous year's £23.2 million. The gross profit margin increased to 34% from 32% in FY 22. These enhanced margins were evident in the growth in revenue per client-facing Partner and underscore our efficacy in increasing the profitability of acquired businesses.

Administrative expenses increased by 26% to £8.6 million, principally reflecting the inclusion of iOLAP for a full year and the non-cash acquired intangible asset amortisation from iOLAP and Insigniam.

Group Adjusted EBITDA grew 24% and was delivered at a 30% margin (FY 22: 29%). The enhanced Adjusted EBITDA margin reflects the improvement in gross profit margin, partially offset by the increase in administrative expenses referred to above.

Group profit before tax grew by 40% to £22.1 million (FY 22: £15.7 million) and was driven by the increase in Adjusted EBITDA and the £2.0 million M&A-related net credit for adjustments to contingent consideration associated with the acquisition of iOLAP.

NET FINANCE EXPENSE

Net finance expense of £0.5 million for FY 23 includes the finance cost of contingent consideration (£0.6 million) and the Group office leases liability (£0.3 million). The decrease in net finance expense was principally driven by finance income on short-term deposits given the rising interest rate environment experienced during FY 23. As at 31 December 2023, the Group has no interest rate risk exposure.

TAXATION

The Group's tax charge for FY 23 was £4.7 million, reflecting a higher effective tax rate of 22% compared with 18% in FY 22. The increase was largely driven by an increase in the UK corporate tax rate from 19% to 25% (effective April 2023 onwards). For further detail on taxation see notes 7 and 8 of the Group and Company Financial Statements. Adjusted profit after tax, used in calculating adjusted EPS, is shown after adjustments for the applicable tax on adjusting items as set out in note 3.

EARNINGS PER SHARE

Adjusted diluted EPS increased by 22% to 37.2p. This was the result of the 18% increase in Adjusted profit after tax, plus a reduction in the weighted average number of shares used as the denominator (due to the settlement of the FY 22 iOLAP earn-out without any dilution of shareholders and FY 23 share price performance). Adjusting items and their tax impacts are set out in note 3 of the Group and Company Financial Statements.

CASH FLOW

The Group's net cash position decreased to £18.1 million (FY 22: £20.4 million), as a result of the Responsum and Insigniam acquisitions, and earn-out payments for iOLAP and Coast Digital.

The Group continued to benefit from strong cash generation with increased net cash flow generated from operations of £16.8 million in FY 23 (FY 22: £15.7 million). The increase in operating cash flow compared to FY 22 was less than the increase in EBITDA due to the increase in tax paid (as explained above) and working capital timing differences (which reversed in January 2024).

Net cash utilised for acquisitions reflects a total of £15.1 million, which is comprised of £7.3 million initial cash consideration for the acquisition of Insigniam (net of cash of £1.1 million acquired on acquisition), £1.3 million initial cash consideration for the acquisition of Responsum, £6.4 million iOLAP earn-out satisfied through shares sold from the EBT in order to minimise dilution plus the final contingent consideration payment of £0.2 million for Coast Digital.

Net cash utilised in financing activities of £4.1 million represents a dividend payment of £4.9 million, net Partner loans (including associated section 455 tax) of £2.0 million, repayment of Responsum debt on acquisition of £0.7 million, office lease payments of £1.0 million, partially offset by net sales of shares from the EBT of £4.6 million.

STATEMENT OF FINANCIAL POSITION

Net assets as at 31 December 2023 totalled £119.6 million (FY 22: £95.9 million). The increase in net assets is as a result of a £4.3 million increase in share premium for share issues for Responsum, Insigniam and the sale of shares at market price to promoted Partners, net of loss on sale of shares by EBT, retained profit for the year of £15.4 million, net EBT share sales of £5.4 million and foreign currency translation losses of £1.5 million.

DIVIDENDS

The Company paid a final Ordinary share dividend in respect of FY 22 of 10.8 pence per share on 18 August 2023.

An interim Ordinary share dividend in respect of FY 23 of 5.3 pence per share was paid on 15 February 2024. The Board is pleased to recommend a final dividend for FY 23 of 9.5 pence per Ordinary share, making a total dividend of 14.8p for the FY 23 financial year, a 37% increase on the FY 22 dividend.

The final dividend will be recommended to shareholders at the AGM in June 2024. The FY 23 final dividend will have a total cash cost of £4.5 million, which will be funded from the Group's existing cash reserves.

Group Statement of Comprehensive Income

For the year ended 31 December 2023

Year ended 31 December 2023Year ended 31 December 2022
Note£'000s£'000s
Revenue485,88571,745
Cost of sales4(56,621)(48,589)
Gross profit29,26423,156
Administrative expenses(8,607)(6,852)
Operating profit before M&A-related items520,65716,304
Depreciation1,1401,061
Amortisation of intangible assets1,6522,004
Share-based payments1,9671,159
Adjusted EBITDA325,41620,528
M&A-related items51,966600
Operating profit522,62316,904
Finance income36554
Finance costs(889)(1,213)
Net finance expense6(524)(1,159)
Profit before taxation522,09915,745
Taxation7(4,861)(2,876)
Profit for the year17,23812,869

Other comprehensive income

Items that may be subsequently reclassified to profit and loss:

Year ended 31 December 2023Year ended 31 December 2022
Note£'000s£'000s
Currency translation on foreign currency net investments(1,500)1,827
Other comprehensive income, net of tax(1,500)1,827
Total comprehensive income15,73814,696
Basic earnings per Ordinary share (p)1037.5327.86
Diluted earnings per Ordinary share (p)1034.1624.78

All results relate to continuing operations.

The notes form part of these accounts.

Group And Company Statements of Financial Position

As at 31 December 2023

GroupCompany
31 December 202331 December 202231 December 202331 December 2022
Note£'000s£'000s£'000s£'000s
Assets
Non-current assets
Intangible assets12100,90583,581--
Property, plant and equipment145,6125,662--
Investments15--95,28785,426
Other receivables161,9851,2931,520876
Loans to shareholders167,6044,7347,6044,723
Deferred tax asset83,4771,719--
Total non-current assets119,58396,989104,41191,025
Current assets
Trade and other receivables1616,68611,234261403
Cash and cash equivalents1718,13020,4336,6596,340
Total current assets34,81631,6676,9206,743
Total assets154,399128,656111,33197,768
Liabilities
Current liabilities
Trade and other payables1819,05613,3046,9097,215
Lease liabilities191,150750--
Corporation tax2683813-
Other creditors201,1446,765-203
Total current liabilities21,61821,2006,9127,418
Net current assets13,19810,4678(675)
Non-current liabilities
Lease liabilities194,2144,393--
Deferred tax liability82,0001,435--
Other non-current liabilities207,0055,713--
Total non-current liabilities13,21911,541--
Total liabilities34,83732,7416,9127,418
Net assets119,56295,915104,41990,350
Equity
Share capital2152525252
Share premium2129,92225,59929,92225,599
Capital redemption reserve2222
EBT share reserve22(1,745)(7,147)(1,745)(7,147)
Merger relief reserve2146,87046,87046,87046,870
Foreign currency translation reserve3781,878--
Retained earnings44,08328,66129,31824,974
Total shareholders' equity119,56295,915104,41990,350

As permitted by section 408 of the Companies Act 2006, a separate statement of comprehensive income of the parent Company has not been presented. The Company's profit for the year was £7.6 million (FY 22: £13.1 million).

The notes form part of these accounts.

The Financial Statements were approved by the Board of Directors on 19 April 2024 and were signed on its behalf by:

Stephen Newton

Director

Group Statement of Changes in Equity

For the year ended 31 December 2023

Share capitalShare premiumCapital redemption reserveEBT share reserveMerger relief reserveForeign currency translation reserveRetained earningsTotal
Group£'000s£'000s£'000s£'000s£'000s£'000s£'000s£'000s
As at 31 December 2021 and 01 January 20225224,9522(2,193)46,8705116,30786,041
Comprehensive income
Profit for the period------12,86912,869
Other comprehensive income-----1,827-1,827
Transactions with owners
Dividends------(1,855)(1,855)
Share-based payments------975975
Deferred tax recognised in equity------365365
Sale of Ordinary shares-647-9,743---10,390
Acquisition of Ordinary shares---(14,697)---(14,697)
As at 31 December 2022 and 01 January 20235225,5992(7,147)46,8701,87828,66195,915
Comprehensive income
Profit for the period------17,23817,238
Other comprehensive income-----(1,500)-(1,500)
Transactions with owners
Ordinary share issues-5,417-----5,417
Dividends------(4,940)(4,940)
Share-based payments------1,6941,694
Deferred tax recognised in equity------1,4301,430
Sale of Ordinary shares-(1,094)-9,322---8,228
Acquisition of Ordinary shares---(3,920)---(3,920)
As at 31 December 20235229,9222(1,745)46,87037844,083119,562

The notes form part of these accounts. Please refer to note 28 for explanations of reserve accounts.

Company Statement of Changes in Equity

For the year ended 31 December 2023

Share capitalShare premiumCapital redemption reserveEBT share reserveMerger relief reserveRetained earningsTotal
Company£'000s£'000s£'000s£'000s£'000s£'000s£'000s
As at 31 December 2021 and 01 January 20225224,9522(2,193)46,87012,77282,455
Comprehensive income
Profit for the period-----13,08213,082
Transactions with owners
Dividends-----(1,855)(1,855)
Share-based payments-----975975
Sale of Ordinary shares-647-9,743--10,390
Acquisition of Ordinary shares---(14,697)--(14,697)
As at 31 December 2022 and 01 January 20235225,5992(7,147)46,87024,97490,350
Comprehensive income
Profit for the period-----7,5907,590
Transactions with owners
Ordinary share issues-5,417----5,417
Dividends-----(4,940)(4,940)
Share-based payments-----1,6941,694
Sale of Ordinary shares-(1,094)-9,322--8,228
Acquisition of Ordinary shares---(3,920)--(3,920)
As at 31 December 20235229,9222(1,745)46,87029,318104,419

The notes form part of these accounts. Please refer to note 28 for explanations of reserve accounts.

Group and Company Cash Flow Statements

For the year ended 31 December 2023

GroupCompany
31 December 202331 December 202231 December 202331 December 2022
Note£'000s£'000s£'000s£'000s
Cash flows from operating activities:
Cash generated from operations2421,98819,5837,08020,364
Taxation paid(5,195)(3,855)(22)(18)
Net cash generated from operating activities16,79315,7287,05820,346
Cash flows from investing activities:
Purchase of property, plant and equipment(62)(329)--
Software development costs(65)---
Payment for acquisition of subsidiary, net of cash acquired(15,063)(18,276)-(203)
Investment in subsidiary--(4,621)(20,643)
Interest received3657125359
Net cash utilised in investing activities(14,825)(18,534)(4,368)(20,787)
Cash flows from financing activities:
EBT Ordinary share purchases(3,773)(14,697)(3,773)(14,697)
EBT Ordinary share sales8,35610,2578,35610,257
Loans to shareholders(2,500)(3,011)(2,500)(3,000)
Loans repaid by shareholders1,1302,2681,1302,268
s455 tax refunded/(paid) re loans to shareholders(644)245(644)232
Repayment of borrowings(687)(1,143)--
Lease liability payments(770)(651)--
Interest paid(236)(262)--
Ordinary share dividends paid to shareholders(4,940)(1,855)(4,940)(1,855)
Net cash utilised in financing activities(4,064)(8,849)(2,371)(6,795)
Net (decrease)/increase in cash and cash equivalents(2,096)(11,655)319(7,236)
Cash and cash equivalents at beginning of the period20,43331,7956,34013,576
Effects of exchange rate changes on cash and cash equivalents(207)293--
Cash and cash equivalents at the end of the period18,13020,4336,6596,340

The notes form part of these accounts.

Notes to the Financial Statements

BASIS OF PREPARATION

1.1. General information

The Company is a public company limited by shares incorporated in England and Wales and domiciled in the UK. The address of the registered office is 12 Helmet Row, London, EC1V 3QJ and the Company number is 11723404.

1.2. Basis of preparation

1.3. Basis of consolidation

These financial statements consolidate the financial statements of the Company and its subsidiary undertakings as at 31 December 2023.

1.4. Measurement convention

The financial statements have been prepared under the historical cost convention, except as otherwise described in the accounting policies.

The preparation of the consolidated financial information in compliance with UK adopted international accounting standards requires the use of certain critical accounting estimates and management judgements in applying the accounting policies. The significant estimates and judgements that have been made and their effect is disclosed in note 2.1.

1.5. Going concern

MATERIAL ACCOUNTING POLICIES

The principal accounting policies adopted in the preparation of the financial statements of the Group and Company, which have been applied consistently to the period presented, are set out below.

2.1. Judgements and key sources of estimation uncertainty

In the process of applying the Group's accounting policies, the Directors have made no judgements (excluding those involving estimations and recognition of intangibles on acquisitions), which are considered to have a significant effect on the amounts recognised in the financial statements for the year ending 31 December 2023.

The key sources of estimation uncertainty that could cause an adjustment to be required to the carrying amount of assets or liabilities within the next accounting period are:

  • Revenue is recognised in line with time worked on a project unless the engagement is conditional or contingent. Management review accrued revenue to determine whether there is any likelihood of any amendments or provisions required based on project progress and relationship with the client.
  • The Group's policy on recognising an impairment of the trade receivables balance is based on a review of individual receivable balances, their ageing and management's assessment of realisation. This review and assessment is conducted on a continuing basis and any material change in management's assessment of trade receivable impairment is reflected in the carrying value of the asset.
  • Provisions for dilapidations are accrued based on estimation of the cost expected to crystallise on vacating leased premises.
  • In determining the fair value of intangible assets arising on business combinations, management is required to estimate the timing and amount of future cash flows applicable to the intangible assets being acquired.
  • Management has estimated the share-based payments expense under IFRS 2. In determining the fair value of share-based payments, management has considered several internal and external factors in order to judge the probability that management and employee share incentives may vest and to assess the fair value of share options at the date of grant. Such assumptions involve estimating a number of future performance and other factors.
  • The Responsum and Insigniam contingent consideration calculations under IFRS 3 contain estimation uncertainty, as the earn-out potentially payable in each case is linked to the future performance of the acquiree. In estimating the fair value of the contingent consideration, at both the acquisition date and financial year end, management has estimated the potential future cash flows of the acquirees and assessed the likelihood of an earn-out payment being made. These estimates could potentially change as a result of events over the coming years.

2.2. Revenue recognition

This occurs as follows for the Group's various contract types:

  • Time-and-materials contracts are recognised over time as services are provided at the fee rate agreed with the client where there is an enforceable right to payment for performance or performance-related elements completed to date.

The Group's standard payment terms require settlement of invoices within 30 days of receipt.

2.3. Business combinations, goodwill and consideration

Business combinations

Goodwill

In accordance with IAS 36, the Group has tested goodwill for impairment at the reporting date. No goodwill impairment was deemed necessary as at 31 December 2023. For further details on the impairment review please refer to note 12.

Contingent and non-contingent deferred consideration on acquisition

2.4. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profits as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Group's and Company's liability for current tax is calculated using tax rates that have been enacted or substantially enacted by the reporting end date.

Deferred tax

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit, and is accounted for using the balance sheet liability method. Deferred tax liabilities are generally recognised for all taxable temporary differences and deferred tax assets are recognised to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilised. Such assets and liabilities are not recognised if the temporary differences arise from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit; and at the time of the transaction, does not give rise to equal taxable and deductible temporary differences.

2.5. Foreign currency translation

Functional and presentational currency

Transactions and balances

2.6. Intangible assets

Intangible assets are measured at cost less accumulated amortisation and any accumulated impairment losses. Intangible assets acquired in a business combination are initially measured at their fair value (which is regarded as their cost). Subsequent to initial recognition, intangible assets acquired in a business combination are reported at cost less accumulated amortisation and any accumulated impairment losses.

Intangible AssetUseful Economic LifeValuation Method
Trademark33.33% reducing balanceRelief from Royalty method
Customer relationships10 - 25% reducing balanceMulti-Period Excess Earnings method
Order bookOver order termMulti-Period Excess Earnings method

2.7. Tangible assets

Costs comprise purchase costs together with any incidental costs of acquisition.

Tangible fixed assetUseful economic life
Leasehold improvementsOver the life of the lease
Computer equipment3 years
Fixtures and fittings3 years

2.8. Impairments of tangible and intangible assets

2.9. Employee benefits

Post-retirement benefits

The Group pays into defined contribution pension schemes on behalf of employees that are operated by third parties. The assets of the schemes are held separately from those of the Group in independently administered funds.

Share-based payments

The cost of share-based employee compensation arrangements, whereby employees receive remuneration in the form of share options, is recognised as an employee benefit expense in the statement of profit and loss.

Please refer to note 23 for further details.

2.10. Earnings per share

The Group presents basic and diluted EPS.

2.11. Financial instruments

The Group classifies financial instruments, or their component parts, on initial recognition as a financial asset, a financial liability or an equity instrument in accordance with the substance of the contractual arrangement. Financial instruments are recognised on trade date when the Group becomes a party to the contractual provisions of the instrument. Financial instruments are recognised initially at fair value plus, in the case of a financial instrument not a fair value through profit and loss, transaction costs that are directly attributable to the acquisition or issue of the financial instrument. Financial instruments are de-recognised on the trade date when the Group is no longer a party to the contractual provisions of the instrument.

Trade and other receivables and trade and other payables

Interest-bearing borrowings

Cash and cash equivalents

Cash and cash equivalents comprise cash balances and call deposits with terms up to 90 days.

Contingent consideration

Contingent deferred consideration may arise on acquisitions where the consideration is dependent on the future performance of the acquired company. In circumstances where the acquiree will receive contingent consideration in a variable number of shares and is not employment-linked, the Group has recognised a financial liability at the fair value of the contingent consideration. Subsequent changes to the fair value of the contingent consideration are recognised in the statement of comprehensive income.

At the balance sheet date the contingent consideration liability represents the fair value of the remaining contingent consideration valued at acquisition. The contingent consideration liability for acquisitions under IFRS 3 contains estimation uncertainty as they relate to future expected performance of the acquired business. In estimating the fair value of the contingent consideration, management have assessed the potential future cash flows of the acquired business and the likelihood of an earn-out payment being made.

2.12. Provisions

A provision is recognised in the statement of financial position when the Group has a present legal or constructive obligation as a result of a past event, that can be reliably measured and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects risks specific to the liability.

2.13. Right-of-use assets: Leases

The Group leases two properties in the UK and five properties outside the UK.

All leases are accounted for by recognising a right-of-use asset and a lease liability, except for leases of low value assets.

Lease liabilities are measured at the present value of contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate inherent in the lease unless (as is typically the case) this is not readily determinable, in which case the lessee's incremental borrowing rate on commencement of the lease is used.

  • Lease payments made at or before commencement of the lease;
  • Initial direct costs incurred; and

When the Group revises its estimate of the term of any lease (because, for example, it re-assesses the probability of a lessee extension or termination option being exercised), it adjusts the carrying amount of the lease liability to reflect the payments to be made over the revised term, which are discounted at the same discount rate that applied on lease commencement. An equivalent adjustment is made to the carrying value of the right-of-use asset, with the revised carrying amount being amortised over the remaining (revised) lease term.

2.14. Financing income and expenses

Financing expenses comprise interest payable, interest on lease liabilities using the effective interest method and the unwinding of the discount on contingent consideration.

Financing income includes interest receivable on funds invested.

2.15. Standards issued but not yet effective

At the date of authorisation of these financial statements, there are no standards that are issued but not yet effective that would be expected to have a material impact on the Group or Company's financial statements in the current or future reporting periods and on foreseeable future transactions.

Alternative performance measures

In order to provide better clarity to the underlying performance of the Group, Elixirr uses adjusted EBITDA and adjusted EPS as alternative performance measures. These measures are not defined under IFRS. These non-GAAP measures are not intended to be a substitute for, or superior to, any IFRS measures of performance, but have been included as the Directors consider adjusted EBITDA and adjusted EPS to be key measures used within the business for assessing the underlying performance of the Group's ongoing business across periods.

Adjusted EBITDA excludes the following items from operating profit: non-cash depreciation and amortisation charges, share-based payments and non-recurring M&A-related items. Adjusted EPS excludes the following items from profit after tax: amortisation charges, share-based payments, non-recurring M&A-related items, M&A-related non-cash finance costs and their related tax impacts.

FY 23FY 22
Group£'000s£'000s
Profit before tax22,09915,745
Adjusting items:
M&A-related items (note 5)(1,966)(600)
Amortisation of intangible assets1,6522,004
Share-based payments1,9671,159
Finance cost - contingent consideration636951
Adjusted profit before tax24,38819,259
Depreciation1,1401,061
Net finance (income)/cost (excluding contingent consideration)(112)208
Adjusted EBITDA25,41620,528
FY 23FY 22
Group£'000s£'000s
Adjusted profit before tax24,38819,259
Tax charge(4,861)(2,876)
Tax impact of adjusting items(761)(531)
Adjusted profit after tax18,76615,852

Potential Ordinary shares are treated as dilutive when their conversion to Ordinary shares would decrease EPS. Please refer to note 10 for further details.

FY 23FY 22
Grouppp
Adjusted EPS40.8634.32
Adjusted diluted EPS37.1930.53
4. Segment reporting & RESTATEMENT
FY 23FY 22
Group£'000s£'000s
Revenue from contracts with customers arises from:
United Kingdom28,52023,837
USA37,53331,703
Rest of World19,83216,205
Total Revenue85,88571,745

IFRS 8 requires that operating segments be identified on the basis of internal reporting and decision-making. The Group is operated as one global business by its executive team, with key decisions being taken by the same leaders irrespective of the geography where work for clients is carried out. Management therefore consider that the Group has one operating segment. As such, no additional disclosure has been provided under IFRS 8.

The Company is a holding Company operating in the UK with its assets and liabilities given in the Company Statement of Financial Position. Other Company information is provided in the other notes to the accounts.

FY 23 revenue includes £0.8m of reimbursable expenses. FY 22 revenue and cost of sales have been restated to reclassify reimbursable expenses as revenue, which was previously reported in cost of sales. The reimbursable expenses revenue was reclassified by restating each of the affected financial statement line items for the prior period as follows:

FY 22IncreaseFY 22 (Restated)
Group£'000s£'000s£'000s
Statement of Comprehensive Income (extract):
Revenue70,7031,04271,745
Cost of sales(47,547)(1,042)(48,589)

Profit before taxation

The following items have been included in arriving at profit before taxation:

FY 23FY 22
Group£'000s£'000s
Depreciation of property, plant and equipment:
- Owned assets233213
- Leased assets907848
Amortisation of intangible assets1,6522,004
Share-based payments1,9671,159
Foreign exchange losses/(gains)388(392)
M&A-related items(1,966)(600)
- Transaction costs956486
- Adjustment to contingent consideration(2,922)(1,086)

The M&A-related net credit of £2.0 million in FY 23 includes adjustments to contingent consideration associated with the acquisition of iOLAP, less non-recurring costs associated with the acquisitions of Insigniam and Responsum as well as other M&A activity. The M&A-related net credit of £0.6 million in FY 22 includes adjustments to contingent consideration associated with the acquisitions of Retearn and iOLAP, less non-recurring costs associated with the acquisition of iOLAP.

During the year the Group obtained the following services from the Company's auditors as detailed below:

FY 23FY 22
Group£'000s£'000s
Services provided by the Company's auditors:
Audit fees - parent Company and consolidated accounts4340
Audit fees - subsidiary companies10789
6. Net finance expense
FY 23FY 22
Group£'000s£'000s
Finance income:
On short term deposits and investments36554
36554
Finance costs:
Finance cost - contingent consideration(640)(951)
On lease liability(249)(262)
(889)(1,213)
Net finance expense(524)(1,159)
7. Taxation on profit on ordinary activities
Analysis of tax charge:
FY 23FY 22
Group£'000s£'000s
Current tax
In respect of the current year5,0353,466
Adjustments in respect of prior periods47(334)
Total current tax5,0823,132
Deferred tax
In respect of the current year(221)(324)
Change in tax rates-68
Total deferred tax(221)(256)
Income tax expense4,8612,876

Numerical reconciliation of income tax expense:

The tax assessed on the profit on ordinary activities for the year is lower than the standard rate of corporation tax in the UK of 25%.

FY 23FY 22
Group£'000s£'000s
Profit before taxation22,09915,745
Profit on ordinary activities multiplied by the weighted average rate of corporation tax in UK of 23.5% (FY 22: 19%)5,1932,992
Effects of:
M&A-related items not taxable(606)-
Expenses not deductible324193
Difference in overseas tax rates(97)201
Change in deferred tax rate-68
Adjustments in respect of prior periods147(62)
R&D tax relief in respect of prior periods(100)(271)
Deferred tax release re trademarks-(245)
Total taxation4,8612,876
8. Deferred tax
Net deferred tax asset/(liability):
The balances comprise temporary differences attributable to:
GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Deferred tax liability
Property, plant and equipment(78)(105)--
Intangible assets(1,922)(1,330)--
Total deferred tax liability(2,000)(1,435)--
Deferred tax asset
Share-based payments3,1171,400--
Short-term timing differences360319--
Total deferred tax asset3,4771,719--
Net deferred tax asset1,477284--

The deferred tax liability on intangible assets relates to trademarks and customer relationships and those on property, plant and equipment relate to accelerated capital allowances.

The deferred tax asset recognised represents the future tax effect of share-based payment charges in respect of options that are yet to vest. Deductions in excess of the cumulative share-based payment charge recognised in the statement of comprehensive income are recognised in equity.

Movements in deferred tax:

Property, plant and equipmentIntangible assetsShare-based paymentsShort-term timing differencesTotal
£'000s£'000s£'000s£'000s£'000s
At 31 December 2021(52)(571)966231574
Acquisition of business-(858)--(858)
Credited to equity--365-365
Credited/(charged) to profit and loss(53)1826958256
Exchange rate difference-(83)-30(53)
At 31 December 2022(105)(1,330)1,400319284
Acquisition of business-(493)--(493)
Credited to equity--1,429-1,429
Credited/(charged) to profit and loss27(152)28858221
Exchange rate difference-53-(17)36
At 31 December 2023(78)(1,922)3,1173601,477

Ordinary dividends

The Company paid a final Ordinary share dividend in respect of FY 22 of 10.8 pence per Ordinary share on 18 August 2023. No interim Ordinary share dividends were paid during FY 22 or FY 23.

An interim Ordinary share dividend in respect of FY 23 of 5.3 pence per Ordinary share was paid on 15 February 2024.

The Board is pleased to recommend a final dividend for FY 23 of 9.5p per share, making a total dividend of 14.8p for FY 23.

The final dividend will be recommended to shareholders at the AGM in June 2024. The FY 23 final dividend will have a total cash cost of £4.5 million, which will be funded from the Group's existing cash reserves.

Earnings per share

Diluted EPS takes into consideration the Company's dilutive contingently issuable shares. The weighted average number of Ordinary shares used in the diluted EPS calculation is inclusive of the number of share options and ESPP matching awards that are expected to vest (subject to the relevant criteria being met) and the number of shares that may be issued to satisfy contingent M&A deferred consideration.

The profits and weighted average number of shares used in the calculations are set out below:

FY 23FY 22
Basic and Diluted EPS
Profit attributable to the Ordinary equity holders of the Group used in calculating basic and diluted EPS (£'000s)17,23812,869
Basic earnings per Ordinary share (p)37.5327.86
Diluted earnings per Ordinary share (p)34.1624.78
FY 23FY 22
Adjusted Basic and Diluted EPS
Profit attributable to the Ordinary equity holders of the Group used in calculating adjusted basic and diluted EPS (note 3) (£'000s)18,76615,852
Adjusted basic earnings per Ordinary share (p)40.8634.32
Adjusted diluted earnings per Ordinary share (p)37.1930.53
FY 23FY 22
NumberNumber
Weighted average number of shares
Weighted average number of Ordinary shares used as the denominator in calculating non-adjusted and adjusted basic EPS45,933,06246,186,481
Number of dilutive shares4,531,3755,740,587
Weighted average number of Ordinary shares used as the denominator in calculating non-adjusted and adjusted diluted EPS50,464,43751,927,068

Employees and directors

The monthly average number of persons employed by the Group during the year, analysed by category, was as follows:

FY 23FY 22
GroupNumberNumber
Directors, management and Partners3231
Provision of services397373
Administration5546
484450

The average number of persons employed and staff costs includes both executive and non-executive Directors.

The aggregate payroll costs of these persons were as follows:

FY 23FY 22
Group£'000s£'000s
Wages and salaries37,83032,702
Social security costs4,3343,910
Pension costs862755
Share-based payment charge1,9671,159
44,99338,526

Defined contribution pension schemes are operated by third parties on behalf of the employees of the Group. The assets of the schemes are held separately from those of the Group in independently administered funds. The pension charge represents contributions payable by the Group to the funds and amount to £0.9 million for FY 23 (FY 22: £0.8 million). Contributions amounting to £0.1 million (FY 22: £0.1 million) were payable to the fund as at 31 December 2023 and are included in payables.

Key management personnel include the Directors and senior managers across the Group who together have authority and responsibility for planning, directing and controlling the activities of the Group. The total compensation (including employers' national insurance) paid in respect of key management personnel for services provided to the Group is as follows:

GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Aggregate emoluments including short term employee benefits5,5114,872200167
5,5114,872200167

The share-based payment charge in respect of key management personnel was £0.3 million (FY 22: £0.2 million).

Details of the Directors' remuneration, including salary, bonus, share option awards, pension and other benefits are included in the tables within the Directors' Report.

Goodwill and intangible fixed assets

GoodwillTrademarksCustomer relationshipsOrder bookSoftwareTotal
Group£'000s£'000s£'000s£ 000's£ 000's£'000s
Cost
At 31 December 202151,4127,1351,874--60,421
Acquisition of business23,391-2,4531,051-26,895
Gains/(losses) from foreign exchange2,172-22798-2,497
At 31 December 202276,9757,1354,5541,149-89,813
Acquisition of business (note 13)18,312-1,54646636420,688
Additions----6565
Gains/(losses) from foreign exchange(1,626)-(161)(67)4(1,850)
At 31 December 202393,6617,1355,9391,548433108,716
Amortisation
At 31 December 2021-(4,071)(157)--(4,228)
Charge for the year-(879)(620)(505)-(2,004)
Gains/(losses) from foreign exchange--1(1)--
At 31 December 2022-(4,950)(776)(506)-(6,232)
Charge for the year-(627)(653)(372)-(1,652)
Gains/(losses) from foreign exchange--3736-73
At 31 December 2023-(5,577)(1,392)(842)-(7,811)
Net book value
At 31 December 202276,9752,1853,778643-83,581
At 31 December 202393,6611,5584,547706433100,905

The Company has no intangible assets.

Goodwill

Goodwill arising on the acquisition of a business in FY 23 relates to the acquisitions of Responsum and Insigniam and was calculated as the fair value of initial consideration paid less the fair value of the net identifiable assets at the date of the acquisition (see note 13).

Goodwill arising on the acquisition of a business in FY 22 relates to the acquisition of iOLAP.

Goodwill impairment review

The breakdown of goodwill by cash-generating unit ('CGU') is listed below:

FY 23FY 22
£'000s£'000s
Consulting61,70048,556
Elixirr Digital2,8562,856
iOLAP and Responsum29,10525,563
93,66176,975

The Consulting CGU comprises goodwill and other assets of Elixirr Consulting Limited, The Retearn Group Limited and the acquisition of Insigniam in FY 23 (refer note 13). The Elixirr Digital CGU comprises goodwill and other assets of Elixirr Digital Limited. The iOLAP CGU comprises goodwill and other assets of iOLAP and the acquisition of Responsum in FY 23 (refer note 13).

Following initial recognition, goodwill is subject to impairment reviews, at least annually, and measured at fair value less accumulated impairment losses. Any impairment is recognised immediately in the consolidated statement of comprehensive income and is not subsequently reversed.

Key assumptions used in value in use calculation

The key assumptions for the value in use calculation are those regarding:

  • number of years of cash flows used and budgeted EBITDA growth rate;
  • discount rate; and
  • terminal growth rate.

No impairment is indicated for any of the CGUs using the value in use calculation.

Number of years of cash flows used and budgeted growth rate

The recoverable amount of the CGU is based on a value in use calculation using specific cash flow projections over a five-year period and a terminal growth rate thereafter.

The budget for the following financial year forms the basis for the cash flow projections for a CGU. The cashflow projections for the four years subsequent to the budget year reflect the Directors' expectations based on market knowledge, numbers of new engagements and the pipeline of opportunities.

Discount rate

The Group's post-tax weighted average cost of capital has been used to calculate a discount rate of 12% for the Group and Consulting, 12% for iOLAP and Responsum, and 13% for Elixirr Digital. This reflects current market assessments of the time value of money for the period under review and the risks specific to the Group and company acquired.

Terminal growth rate

An appropriate terminal growth rate is selected, based on the Directors' expectations of growth beyond the five-year period. The terminal growth rate used is 2%.

Sensitivity to changes in assumptions

With regard to the value in use assumptions, the Directors believe that reasonably possible changes in any of the above key assumptions would not cause the carrying value of the unit to exceed its recoverable amount. In forming this view, the Directors have considered the following:

ConsultingElixirr DigitaliOLAP
FY 23FY 22FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s£'000s£'000s
On current cash flow projections, the discount rate would need to exceed the % alongside for there to be any impairment; and28.1%30.5%71.4%50.0%21.9%23.7%
In the case of no increase in future cash flows above those projected for the following year, the discount rate would have to exceed the % alongside for there to be any impairment.22.7%25.0%58.8%42.7%17.9%19.0%

Customer relationships

FY 23 additions represent the fair value of customer relationships from the acquisition of Insigniam. Refer to note 13 for further details.

The fair value has been determined by applying the Multi-Period Excess Earnings method to the cash flows expected to be earned from customer relationships. The key management assumptions are in relation to forecast revenues, margins and discount factors. The fair value represents the present value of the earnings the customer relationships generate.

A useful economic life of 10 years has been deemed appropriate based on the average realisation rate of cumulative cash flows. The projected cash flows have been discounted over this period. The amortisation charge since acquisition is recognised within administrative expenses.

FY 22 additions represent the fair value of customer relationships from the acquisition of iOLAP.

Order Book

FY 23 additions represent the fair value of the order book from the acquisition of Insigniam. Refer to note 13 for further details.

The fair value has been determined by applying the Multi-Period Excess Earnings method to the cash flows earned from the order book. The key management assumptions relate to forecast margins and discount factors.

A useful economic life of 1 year has been deemed appropriate based on the relevant contractual period. Projected cash flows have been discounted over this period. The amortisation charge is recognised within administrative expenses.

FY 22 additions represent the fair value of the order book from the acquisition of iOLAP.

Business combinations

On 15 September 2023, the Group, through its US subsidiary iOLAP, acquired 100% of the share capital and voting interests of Responsum, Inc. a US-headquartered firm which has developed proprietary artificial intelligence software. The acquisition brings specialist services in emerging technology, large language models ("LLM") and generative AI into the Group, complementing the Group's existing service offering and iOLAP Inc.'s ("iOLAP") data and analytics capabilities in particular.

The Group acquired Responsum for a maximum consideration payable of £5.1 million (US$6.4 million). The consideration consists of:

  • An initial consideration of £1.6 million (US$2.0 million) in cash;
  • An initial consideration of £2.7 million (US$3.4 million) settled through the issue of 505,196 Ordinary shares at a price of £5.40 per share;
  • Potential earn-out payments of up to £0.8 million (US$1.0 million) in cash which are contingent on iOLAP and Responsum together achieving EBIT margin targets in periods up to 31 December 2026.

The Ordinary shares purchased pursuant to the acquisition are subject to restrictions on sale for a total period of up to four years. The sellers also agreed to three-year restrictive covenants.

The difference between the fair value of the purchase consideration of £4.6 million and the fair value of the identifiable assets acquired and liabilities assumed was recognised as goodwill of £5.0 million. The goodwill is attributable to the company's workforce and working methodologies.

The total fair value of the contingent consideration payable recognised on the date of acquisition was £0.4 million (US$0.5 million), of which £0.1 million (US$0.2 million) was the hold back for warranties and £0.3million (US$0.3 million) related to the present value of potential earn-out payments.

The contingent consideration for potential earn-out payments is discounted to fair value and has been estimated by management based on anticipated future revenue growth and EBIT. Discount unwinding is recognised in finance costs proportionately across the periods until final settlement. During the period, £9k of discount unwinding was expensed as finance costs in relation to the Responsum acquisition consideration.

As at 31 December 2023, a £0.4 million liability is recorded, of which £0.1 million is a current and £0.3 million is a non-current liability.

Included within M&A-related items is an amount of £0.1 million for legal and advisory fees in relation to the acquisition.

The table below sets out the amounts recognised as of the acquisition date for each major class of assets acquired and liabilities assumed, the consideration and goodwill on the acquisition of Responsum:

Fair value

£'000s

Assets

Non-current assets

Intangible assets364
Total non-current assets364
Total assets364
Liabilities
Current liabilities
Trade and other payables80
Total current liabilities80
Non-current liabilities
Loans and borrowings687
Total non-current liabilities687
Total liabilities767
Fair value of net assets acquired(403)
Goodwill (note 12)5,044
Fair value of purchase consideration4,641
Cash and cash equivalents in subsidiary acquired-

On 8 December 2023, the Group's US subsidiary, Elixirr, Inc. acquired all of the issued and outstanding membership interests of Insigniam LLC, and Elixirr International plc acquired the entire issued and outstanding shares of Insigniam SAS (Insigniam SAS together with Insigniam LLC, "Insigniam"). Insigniam is a US-headquartered consultancy firm specialising in supporting clients and executives to define and navigate large scale change and transformation. The acquisition brings specialist services in transformation, leadership alignment, cultural change, and executive coaching, complementing the Group's existing service offerings.

The Group acquired Insigniam for a maximum consideration payable of £14.7 million (US$18.5 million). The consideration consists of:

  • An initial consideration of £9.2 million (US$11.6 million) in cash;
  • An initial consideration of £1.2 million (US$1.5 million) settled through the issue of 258,553 Ordinary shares at a price of £4.60 per share;
  • Contingent consideration of up to £4.3 million (US$5.4 million) in either cash or Ordinary shares with, at a minimum, 33% of the contingent consideration being satisfied in cash. This is contingent on Insigniam achieving both revenue growth and EBITDA margin targets in financial periods up to 31 December 2026.

The difference between the fair value of the purchase consideration of £13.8 million and the fair value of the identifiable assets acquired and liabilities assumed of £0.5 million was recognised as goodwill of £13.3 million. The goodwill is attributable to the company's workforce and working methodologies and is deductible for tax purposes.

The total fair value of the contingent consideration payable recognised on the date of acquisition was £4.2 million (US$5.3 million), of which £0.8 million (US$1.0 million) was the hold back for warranties and £3.4million (US$4.3 million) related to the present value of the maximum potential earn-out payments.

The contingent consideration for potential earn-out payments is discounted to fair value and has been estimated by management based on anticipated future revenue growth and EBITDA. Discount unwinding is recognised in finance costs proportionately across the periods until final settlement. During the period, £24k of discount unwinding was expensed as finance costs in relation to the Insigniam acquisition consideration.

As at 31 December 2023, a £4.2 million liability is recorded, of which £0.8 million is a current and £3.4 million is a non-current liability.

Included within M&A-related items is an amount of £0.4 million for legal and advisory fees in relation to the acquisition.

Insigniam contributed £0.9 million to the Group's revenue and £0.1 million to the Group's profit before tax for the period from the date of acquisition to 31 December 2023.

If the acquisition of Insigniam had been completed on 1 January 2023, Group revenues for the year ended 31 December 2023 would have been £95.9 million and Group profit before tax would have been £23.8 million.

In calculating the goodwill arising, the fair value of the net assets of Insigniam have been assessed, and fair value adjustments were required for the recognition of customer relationship and order book intangibles and the related deferred tax.

Customer relationships and order book intangibles were assessed to be separately identifiable assets, recognised at fair value and are included within intangible assets below. Refer to note 12 for further details.

The table below sets out the amounts recognised as of the acquisition date for each major class of assets acquired and liabilities assumed, the consideration and goodwill on the acquisition of Insigniam:

Fair value

£'000s

Assets

Non-current assets

Intangible assets2,012
Property, plant and equipment400
Other receivables67
Total non-current assets2,479
Current assets
Trade and other receivables1,914
Cash and cash equivalents1,118
Total current assets3,032
Total assets5,511
Liabilities
Current liabilities
Trade and other payables4,102
Total current liabilities4,102
Non-current liabilities
Loans and borrowings395
Deferred tax liability493
Total non-current liabilities888
Total liabilities4,990
Fair value of net assets acquired521
Goodwill (note 12)13,268
Fair value of purchase consideration13,789
Cash and cash equivalents in subsidiary acquired1,118
14. Property, plant and equipment
Right of use assetFurniture and FittingsLeasehold ImprovementsComputer EquipmentTotal
Group£'000s£'000s£'000s£'000s£'000s
Cost
At 31 December 20216,427895051887,209
Acquisition of business (note 13)655562690827
Additions-13113464329
Gains from foreign exchange5152563
At 31 December 20227,1332816673478,428
Acquisition of business (note 13)400---400
Additions6393455701
Losses from foreign exchange(23)(4)-(14)(41)
At 31 December 20238,1492806713889,488
Depreciation
At 31 December 2021(1,321)(70)(225)(97)(1,713)
Charge for the year(848)(29)(86)(98)(1,061)
Gains from foreign exchange7--18
At 31 December 2022(2,162)(99)(311)(194)(2,766)
Charge for the year(907)(42)(98)(93)(1,140)
Gains from foreign exchange115-1430
At 31 December 2023(3,058)(136)(409)(273)(3,876)
Net book value
At 31 December 20224,9711823561535,662
At 31 December 20235,0911442621155,612

The Company has no property, plant and equipment.

The lease liability in respect of the right-of-use asset was £5.4 million (FY 22: £5.1 million) and relates to property leases.

Investments

Group companies

Company£'000s
Cost/carrying value
At 31 December 202163,807
Capitalisation of subsidiary20,643
Group companies share-based payments975
At 31 December 202285,426
Acquisition of business1,070
Capitalisation of subsidiary7,098
Group companies share-based payments1,693
At 31 December 202395,287

The Group has no investments.

The Company has the following subsidiary undertakings at the year-end:

Subsidiary undertakingsCountry of incorporationPrincipal activityRegistered officeFY 23FY 22
Elixirr Consulting LimitedEngland and WalesConsultancy12 Helmet Row, London, EC1V 3QJ100%100%
Elix-IRR Consulting Services (South Africa) Limited (indirect)England and WalesServices to the Group12 Helmet Row, London, EC1V 3QJ100%100%
Elixirr LLC (indirect)United StatesConsultancy2711 Centerville Road, Suite 400, Wilmington, Delaware 19808100%100%
Den Creative LimitedEngland and WalesConsultancy12 Helmet Row, London, EC1V 3QJ100%100%
Elixirr Services Limited (indirect)England and WalesDormant12 Helmet Row, London, EC1V 3QJ100%100%
Coast Digital Limited*England and WalesConsultancy12 Helmet Row, London, EC1V 3QJ100%100%
The Retearn Group LimitedEngland and WalesConsultancy12 Helmet Row, London, EC1V 3QJ100%100%
Elixirr Consulting (Jersey) LimitedJerseyConsultancy3rd Floor, 44 Esplanade, St Helier, Jersey, JE4 9WG100%100%
Elixirr Inc.United StatesHolding Company2600 Network Blvd Suite 570 Frisco, TX 75034100%100%
iOLAP Inc. (indirect)United StatesConsultancy2600 Network Blvd Suite 570 Frisco, TX 75034100%100%
iOLAP d.o.o. (indirect)CroatiaConsultancyProlaz Marije Krucifikse Kozulić 1, 51000, Rijeka100%100%
Elixirr GmbHGermanyDormantRonsbachweg 6, 36093, Kuenzell. Germany100%-
Responsum, Inc. (indirect)United StatesConsultancy2600 Network Blvd Suite 570 Frisco, TX 75034100%-
Insigniam LLC (indirect)United StatesConsultancy301 Woodbine Ave, Narberth, PA 19072100%-
Insigniam SASFranceConsultancy36 Rue De Ponthieu, 75008, Paris 8100%-

* On 2 January 2024 the name of Coast Digital Limited was changed to Elixirr Digital Limited.

Receivables

GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Non-current assets
Loans to shareholders7,6044,7347,6044,723
Other receivables1,9851,2931,520876
9,5896,0279,1245,599
Current assets
Trade receivables15,29510,355--
Less: allowance for doubtful debts-(8)--
Trade receivables - net15,29510,347--
Prepayments and deposits8406536362
Contract assets28826--
Amounts owed by group companies---199
Other receivables263208198142
16,68611,234261403

The Company was due £0.2 million as at 31 December 2022 from Elixirr Inc. for costs relating to the acquisition of iOLAP.

Loans to shareholders in FY 23 represent amounts owed to the Company by shareholders, who are senior employees of the Group. The loans to shareholders are interest-free and expected to be repaid beyond one year. Non-current other receivables include property deposits and section 455 tax receivable.

Trade receivables are non-interest bearing and receivable under normal commercial terms. Management considers that the carrying value of trade and other receivables approximates to their fair value. The carrying value of non-current other receivables and loans to shareholders is considered to be a reasonable approximation of their fair value, but has not been discounted to present value.

The expected credit loss on trade and other receivables was not material at the current or prior year ends. For analysis of the maximum exposure to credit risk, please refer to note 25.

The ageing of trade receivables of the Group as at 31 December 2023:

Gross carrying amountLoss allowanceNet carrying amount
Group£'000s£'000s£'000s
< 31 days9,916-9,916
31-60 days3,451-3,451
61-90 days1,662-1,662
91-120 days36-36
121+ days230-230
At 31 December 202315,295-15,295

The ageing of trade receivables of the Group as at 31 December 2022:

Gross carrying amountLoss allowanceNet carrying amount
Group£'000s£'000s£'000s
< 31 days6,171-6,171
31-60 days3,607-3,607
61-90 days450-450
91-120 days1-1
121+ days126(8)118
At 31 December 202210,355(8)10,347
17. Cash and cash equivalents
GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Cash at bank and in hand18,13020,4336,6596,340
18,13020,4336,6596,340

Cash at bank includes £6.2 million on 32-day notice deposit which earned interest at an average rate of 4.2% during the year.

Trade and other payables

GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Trade payables1,7741,17824155
Other taxes and social security costs1,8991,54087
Accruals11,3088,599450156
Contract liabilities3,9381,983--
Other payables1374116-
Amounts owed to group companies--6,0946,997
19,05613,3046,9097,215

As at 31 December 2023, the Company owed £6.1 million (FY 22: £7.0 million) to Elixirr Consulting Limited.

Trade payables comprise amounts outstanding for trade purchases and ongoing costs.

LEASE LIABILITIES

GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Current liabilities
Right of use lease liability1,150750--
1,150750--
Non-current liabilities
Right of use lease liability4,2144,393--
4,2144,393--

The movement in the right of use lease liability was as follows:

Right of use lease liability

Group£'000s
At 31 December 20215,245
Acquisition of business (note 13)555
Interest payable262
Repayment of lease liabilities(913)
Losses from foreign exchange(6)
At 31 December 20225,143
Acquisition of business (note 13)395
Additions639
Interest payable249
Repayment of lease liabilities(1,006)
Losses from foreign exchange(56)
At 31 December 20235,364

The acquisition of business in FY 23 relates to the acquisition of Insigniam. The additions in FY 23 relate to a new property lease signed by iOLAP d.o.o.

The acquisition of business in FY 22 relates to the acquisition of iOLAP.

Maturity analysis of contracted undiscounted cashflows of the right of use lease liability are as follows:

FY 23FY 22
£'000s£'000s
Lease liability less than one year1,334932
Lease liability greater than one year and less than five years3,7213,270
Lease liability greater than five years1,0921,871
Total liability6,1476,073
Finance charges included above(783)(930)
5,3645,143
20. Other creditors and other non-current liabilities
GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Other creditors
Contingent consideration1,1446,765-203
1,1446,765-203
Other non-current liabilities
Dilapidations377380--
Cash-settled share-based payments360139--
Contingent consideration6,2685,194--
7,0055,713--

Contingent consideration in FY 23 include earn-out payments which are contingent on performance and arose from the acquisition of iOLAP, Responsum and Insigniam.

Contingent consideration in FY 22 include earn-out payments which are contingent on performance and arose from the acquisition of Coast Digital and iOLAP.

Other non-current liability payments fall due beyond 12 months from the reporting date.

Share capital, share premium and merger relief reserve

FY 23

Issued sharesPar valueMerger relief reserveShare premium
Group and CompanyNumber££'000s£'000s
£0.00005 Ordinary shares47,272,8112,36446,87029,922
£1 Redeemable Preference shares50,00150,001--
47,322,81252,36546,87029,922
FY 22
Issued sharesPar valueMerger relief reserveShare premium
Group and CompanyNumber££'000s£'000s
£0.00005 Ordinary shares46,186,4812,30946,87025,599
£1 Redeemable Preference shares50,00150,001--
46,236,48252,31046,87025,599

The total number of voting rights in the Company at 31 December 2023 was 47,272,811 (FY 22: 46,186,481).

Ordinary shares

Movements in Ordinary shares:

Issued sharesPar valueMerger relief reserveShare premium
Group and CompanyNumber££'000s£'000s
At 31 December 202146,186,4812,30946,87024,952
Sale of Ordinary shares from the EBT---647
At 31 December 202246,186,4812,30946,87025,599
Share issues1,086,33054-5,417
Sale of Ordinary shares from the EBT---(1,094)
At 31 December 202347,272,8112,36446,87029,922

Share issues in FY 23 represented consideration for the acquisitions of Responsum and Insigniam as well as the sale of shares at market price to promoted Partners.

Redeemable Preference shares

The Redeemable Preference shares are entitled to dividends at a rate of 1% per annum of paid up nominal value. The shares have preferential right, before any other class of share, to a return of capital on winding-up or reduction of capital or otherwise of the Company.

The Redeemable Preference shares are redeemable 100 years from the date of issue or at any time prior at the option of the Company.

EBT share reserve

The Employee Benefit Trust ('EBT') is accounted for under IFRS 10 and is consolidated on the basis that the parent has control, thus the assets and liabilities of the EBT are included on the Company and Group statement of financial position and shares held by the EBT in the Company are presented as a deduction from equity. The EBT share reserve comprises of Ordinary and Redeemable Preference shares bought and held in the Group's EBT.

The below table sets out the number of EBT shares held and their weighted average cost:

FY 23

Shares held in EBTWeighted average costTotal cost
Group and CompanyNumber££'000s
Ordinary shares397,6674.261,695
Redeemable Preference shares50,0011.0150
447,6681,745
FY 22
Shares held in EBTWeighted average costTotal cost
Group and CompanyNumber££'000s
Ordinary shares1,204,9655.897,097
Redeemable Preference shares50,0011.0150
1,254,9667,147

Share-based payments

The Group recognised a total share-based payment expense of £2.0 million (FY 22: £1.2 million) in the current year, comprising £1.7 million (FY 22: £1.0 million) in relation to equity settled share-based payments, and £0.3 million (FY 22: £0.2 million) relating to relevant social security taxes.

A cash-settled share-based payment liability is recognised relating to social security tax on share options (refer to note 20). The liability has been estimated using a closing share price of £6.20 and employers' national insurance at 13.8%. The carrying value of the liability as at 31 December 2023 is £0.4 million (FY 22: £0.1 million), with £0.3 million (FY 22: £0.2 million) recognised in the P&L and payments amounting to £0.1 million (FY 22: £0.1 million) made in the year.

Share Option Plans

During FY 23, a total of 5,614,145 (FY 22: 3,687,080) share options were granted to employees and senior management. The weighted average fair value of the options awarded in the year is £1.17 per share (FY 22: £1.66).

During FY 23, options issued between April 2021 and April 2023 were repriced to an exercise price of £5.20. The weighted average incremental fair value granted as a result of this modification was £0.30. The incremental fair value was measured as the difference between the fair value of the repriced share option and that of the original share option, both estimated as at the date of the modification. The incremental fair value is recognised as an expense over the remaining vesting period from the modification date.

Details of share option awards made are as follows:

Number of share options (000's)Weighted average exercise price
Outstanding at the beginning of the year10,8863.47
Granted during the year5,6145.22
Exercised during the year(57)2.34
Forfeited during the year(2,875)4.28
Outstanding at the year end13,5683.76
Exercisable at the year end2935.54

For the options exercised during FY 23, the weighted average share price at the date of exercise was £5.05.

The options outstanding as at 31 December 2023 had a weighted average remaining contractual life of 2.6 years (FY 22: 3 years) and a weighted average exercise price of £3.76 (FY 22: £3.47) per share.

The options were fair valued at the grant date using the Black Scholes option valuation model.

The inputs into the model were as follows:

FY 23FY 22
Weighted average share price at grant date (£)4.985.90
Weighted average exercise price (£)5.226.32
Volatility (%)27.00%26.54%
Weighted average vesting period (years)55
Risk free rate (%)4.28%1.73%
Expected dividend yield (%)2.54%0.71%

Expected volatility was determined by calculating the historic volatility of comparable companies in the market in which the Group operates. The expected expense calculated in the model has been adjusted, based on management's best estimate, for the effects of non-market-based performance conditions and employee attrition.

Reasonable changes in the above inputs do not have a material impact on the share-based payment charge in FY 23.

Fixed Consideration Options

In addition to the share options set out in the table above, share options with an exercise price of £0.00005 were issued in connection with the acquisition of Elixirr Digital. These share options are for a fixed monetary consideration where the number of share options is variable and determined with reference to the share price at the date of vesting.

The monetary value of such share options is as follows:

Value £'000s

Outstanding at the beginning of the period797
Exercised during the year(297)
Outstanding at the year end500
Exercisable at the year end-

The share price at the date of exercise of the Coast Digital options was £4.74.

The weighted average remaining contractual life of such options at 31 December 2023 was 0.5 years (FY 22: 1.5 years).

Employee Share Purchase Plan ('ESPP')

During FY 23, the Company awarded 184,546 (FY 22: 89,841) matching shares on the basis of one matching share for every one employee share purchased during FY 22. The matching shares vest equally over a 5-year period with the first tranche vesting on 31 January 2024.

Details of ESPP awards made are as follows:

Number of ESPP awards (000's)

Outstanding at the beginning of the period78
Granted during the year185
Vested and converted to shares during the year(15)
Forfeited during the year(44)
Outstanding at the year end204
Exercisable at the year end-
24. Cash flow information
Cash generated from operations:
GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Profit before taxation22,09915,7457,61713,078
Adjustments for:
Depreciation and amortisation2,7923,065--
Net finance expense/(income)5241,159(253)(55)
Share-based payments1,9671,159--
Adjustment to contingent consideration(2,922)(1,086)-(1,400)
Foreign exchange388(392)(4)-
(Increase)/decrease in trade and other receivables(3,812)9751861,660
Increase/(decrease) in trade and other payables952(1,042)(422)7,081
21,98819,5837,12420,364
Reconciliation of liabilities from financing activities:
BorrowingsLeasesTotal
Group£'000s£'000s£'000s
Balance 31 December 2021-5,2455,245
Cash flows(1,143)(913)(2,056)
Other changes1,1438111,954
Balance 31 December 2022-5,1435,143
Cash flows(687)(1,006)(1,693)
Other changes6871,2271,914
Balance 31 December 2023-5,3645,364

Other changes in FY 23 include non-cash movements, additional property leases on acquisition of Insigniam and accrued interest expense on leases. Other changes in FY 22 include non-cash movements, including borrowings and additional property leases on acquisition of iOLAP and accrued interest expense on leases.

Financial instruments and financial risk management

Carrying amount of financial instruments

The Group's and Company's financial instruments may be analysed as follows:

GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Financial assets
Financial assets that are debt instruments measured at amortised cost43,36737,02715,95612,327
Financial liabilities
Financial liabilities measured at amortised cost11,21316,9076,4517,208
Financial liabilities at fair value through profit and loss8,14911,959-203

Financial assets measured at amortised cost comprise cash, trade receivables and other receivables.

Financial liabilities measured at amortised cost comprise loans and borrowings, trade payables and other payables.

Financial liabilities at fair value through profit and loss comprise contingent consideration on the acquisitions of iOLAP, Responsum and Insigniam.

The Group is exposed to a variety of financial risks through its use of financial instruments which result from its operating activities. All of the Group's financial instruments are classified as loans and receivables.

The Group does not actively engage in the trading of financial assets for speculative purposes. The most significant financial risks to which the Group is exposed are described below.

Credit risk

Generally, the Group's and Company's maximum exposure to credit risk is limited to the carrying amount of the financial assets recognised at the reporting date, as summarised below:

GroupCompany
FY 23FY 22FY 23FY 22
£'000s£'000s£'000s£'000s
Trade receivables15,29510,347--
Contract assets28826--
Other receivables9,6546,2219,2835,784
Cash and cash equivalents18,13020,4336,6596,340
43,36737,02715,94212,124

Credit risk is the financial risk to the Group if a counter party to a financial instrument fails to meet its contractual obligation. The nature of the Group's debtor balances, the time taken for payment by clients and the associated credit risk are dependent on the type of engagement.

The Group's trade and other receivables are actively monitored. The ageing profit of trade receivables is monitored regularly by management. Any debtors over 30 days are reviewed by the management group every week and explanations sought for any balances that have not been recovered.

Other receivables include amounts owed by senior employees for the acquisition of shares in the Company. The EBT holds legal title to these shares which will not be released to the beneficial owner prior to the repayment of the loan.

Cash and cash equivalents is split across multiple counterparties and the Group actively monitors the exposure to different financial institutions.

The Directors are of the opinion that there is no material credit risk at Group level.

Liquidity risk

Liquidity risk is the risk that the Group will encounter difficulty in meeting its obligations associated with its financial liabilities. The Group seeks to manage financial risks to ensure sufficient liquidity is available to meet foreseeable needs and to invest cash assets safely and profitably.

The table below analyses the Group's financial liabilities into relevant maturity groupings based on their contractual maturities. The amounts disclosed in the tables are the contractual undiscounted cash flows. Balances due within 12 months equal their carrying balances, because the impact of discounting is not significant.

Contractual maturities of financial liabilities of the Group as at 31 December 2023:

Less than 6 months6-12 months1 - 2 years2 - 5 yearsOver 5 yearsTotal contractual cashflowsCarrying amount of liabilities
Trade payables1,774----1,7741,774
Lease liabilities6766581,0402,6811,0926,1475,364
Financial liabilities at fair value through profit and loss1,144-4,6803,597-9,4218,149
3,5946585,7206,2781,09217,34215,287

Contractual maturities of financial liabilities of the Group as at 31 December 2022:

Less than 6 months6-12 months1 - 2 years2 - 5 yearsOver 5 yearsTotal contractual cashflowsCarrying amount of liabilities
Trade payables1,178----1,1781,178
Lease liabilities4964368752,3951,8716,0735,143
Financial liabilities at fair value through profit and loss6,765-3,0733,073-12,91111,959
8,4394363,9485,4681,87120,16218,280

Interest rate risk

As at 31 December 2023 the Group has no material interest rate risk exposure.

Foreign currency risk

The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily US Dollars. The Group monitors exchange rate movements closely and ensures adequate funds are maintained in appropriate currencies to meet known liabilities.

The Group's exposure to foreign currency risk at the end of the reporting period, expressed in Currency Units, was as follows:

FY23FY22
USD '000sEUR '000sZAR '000sUSD '000sEUR '000sZAR '000sCAD '000sHRK '000s
Cash & cash equivalents5,0251,03196,90611,257313270
Trade receivables7,308829-6,70972-28149
Trade payables(631)(206)(178)(124)(7)(132)0(649)

The Group is exposed to foreign currency risk on the relationship between the functional currencies of the Group companies and the other currencies in which the Group's material assets and liabilities are denominated. The table below summaries the effect on profit and loss had the functional currencies of the Group weakened or strengthened against these other currencies, with all other variables held constant.

FY 23FY 22
£'000s£'000s
10% weakening of functional currency230219
10% strengthening of functional currency(230)(219)

Fair value of financial instruments

The fair values of all financial assets and liabilities approximates to their carrying value.

Capital risk management

The Group defines capital as being share capital plus all reserves, which amounted to £119.6 million as at 31 December 2023 (FY 22: £95.9 million).

The Group's objectives when managing capital are to:

  • Maintain an optimal capital structure to provide a capital-efficient return to shareholders.
  • Related party disclosures

Related parties, following the definitions in IAS 24, are the Group's subsidiary companies, members of the Board, key management personnel and their families, and shareholders who have control or significant influence over the Group. Refer to note 11 for key management personnel compensation disclosures. The Directors' Report contains details of Board remuneration.

In FY 23, travel and marketing costs include £6,550 (FY 22: £43,956) for the hire of an aeroplane from Aviation E LLP. Stephen Newton, a member of the Board, is a member of Aviation E LLP.

Company related party transactions are disclosed in notes 16 and 18.

Events after the reporting date

An interim Ordinary share dividend in respect of FY 23 of 5.3 pence per Ordinary share was paid on 15 February 2024.

The Directors are proposing a final Ordinary share dividend in respect of FY 23 of 9.5 pence per share.

As at 19 April 2024, in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company continues to have 47,272,811 Ordinary shares in issue, of which none are held in Treasury.

The total number of voting rights in the Company is 47,272,811. This figure of 47,272,811 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Reserves

Share capital

Share capital represents the nominal value of share capital subscribed.

Share premium

Capital redemption reserve

EBT share reserve

The EBT share reserve represents the cost of shares repurchased and held in the employee benefit trust ("EBT").

Merger relief reserve

Foreign currency translation reserve

Retained earnings

Ultimate controlling party

There is no ultimate controlling party as at 31 December 2023.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note